[Click e-Stock] "L&C Bio's Stock Reflects Growth Momentum from Next-Generation Skin Boosters"

On September 16, Yuanta Securities analyzed that the recent surge in L&C Bio's stock price was driven by heightened investor interest in the growth momentum of next-generation skin boosters, particularly centered around "Elravie Rituo."

Lee Seungeun, a researcher at Yuanta Securities, stated, "L&C Bio's share price has soared by 120% compared to September 1. The number of clinics and hospitals offering Rituo procedures has doubled from 500 in July 2024 to 1,000 currently, putting the year-end target of 2,000 within reach. This rapid penetration rate has already fueled expectations for revenue growth."

According to the company, Elravie Rituo utilizes human dermis-derived extracellular matrix (ECM) to directly replenish collagen, elastin, and hyaluronic acid, providing immediate improvement after the procedure and long-lasting effects.

Researcher Lee added, "Sales have already begun in Singapore, and strategies for expansion into Southeast Asia and the Middle East are underway. In addition, a recent surge in institutional buying has pushed trading volume to its highest level of the year, further strengthening the stock's momentum. Despite the short-term spike, strong expectations for additional earnings momentum are highlighting a growth premium over valuation concerns."

Lee also predicted that Elravie Rituo's production capacity will double, supporting continued growth. "As of the first half of 2025, production capacity has doubled compared to the previous year, and the utilization rate has reached about 60%," he said. "Production capacity (CAPA) is estimated at around 10 billion KRW, and it can be expanded to approximately 20 billion KRW without difficulty."

He further explained, "More than 95% of raw materials are supplied by U.S. tissue banks, and with certification from the American Association of Tissue Banks (AATB), the company has secured global standards for stability and safety. Currently, more than two years' worth of raw materials have been secured in advance, minimizing supply chain risks. This is expected to provide stable support for revenue growth in line with the pace of channel expansion."